例如:"lncRNA", "apoptosis", "WRKY"

Identification of common non-coding variants at 1p22 that are functional for non-syndromic orofacial clefting.

Nat Commun. 2017 Mar 13;8:14759
Huan Liu 1 , Elizabeth J Leslie 2 , Jenna C Carlson 3 , Terri H Beaty 4 , Mary L Marazita 5 , Andrew C Lidral 6 , Robert A Cornell 7
Huan Liu 1 , Elizabeth J Leslie 2 , Jenna C Carlson 3 , Terri H Beaty 4 , Mary L Marazita 5 , Andrew C Lidral 6 , Robert A Cornell 7
+ et al

[No authors listed]

Author information
  • 1 State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei 430079, China.
  • 2 Center for Craniofacial and Dental Genetics, Department of Oral Biology, School of Dental Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15219, USA.
  • 3 Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
  • 4 Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.
  • 5 Department of Human Genetics, Graduate School of Public Health and Clinical and Translational Science Institute, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15219, USA.
  • 6 Department of Orthodontics, College of Dentistry, University of Iowa, Iowa City, Iowa 52246, USA.
  • 7 Department of Anatomy and Cell Biology, College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA.

摘要


Genome-wide association studies (GWAS) do not distinguish between single nucleotide polymorphisms (SNPs) that are causal and those that are merely in linkage-disequilibrium with causal mutations. Here we describe a versatile, functional pipeline and apply it to SNPs at 1p22, a locus identified in several GWAS for non-syndromic cleft lip with or without cleft palate (NS CL/P). First we amplified DNA elements containing the ten most-highly risk-associated SNPs and tested their enhancer activity in vitro, identifying three SNPs with allele-dependent effects on such activity. We then used in vivo reporter assays to test the tissue-specificity of these enhancers, chromatin configuration capture to test enhancer-promoter interactions, and genome editing in vitro to show allele-specific effects on ARHGAP29 expression and cell migration. Our results further indicate that two SNPs affect binding of CL/P-associated transcription factors, and one affects chromatin configuration. These results translate risk into potential mechanisms of pathogenesis.